Hello, everyone. A spot of rain is falling here on the Pharmalot corporate campus today. Nonetheless, our spirits remain sunny. Why? We are compelled to offer our periodic reminder, courtesy of the Morning Mayor: 'Every brand new day should be unwrapped like a precious gift.' So go ahead and tug on the ribbon. Meanwhile, please join us for a cup of stimulation as we scan the news of the world. Have a great day...
Sanofi-Aventis To Bid $18 Billion For Genzyme (Bloomberg News)
FDA Considers Changes To REMS Safeguards (Reuters)
Lilly Dumps Amazon Web Services Over Legal Struggle (SearchCloudComputing)
Sanofi-Aventis Lawsuit Over Zimulti Is Reinstated (Bloomberg News)
Fewer ABPI Complaints In 2009, But More Appeals (PharmaTimes)
Lilly Loses Appeal In Gemzar Patent Case (Dow Jones)
Mylan Plans Solid-Dose Packaging Plant In Hungary (InPharmaTechnologist)
1 Comment
Based on last years sales, Genzyme has a market capitalization of about $22 billion dollars. I predict that under pressure from shareholders and the Genzyme Board of Directors, the two companies will split the difference and Sanofi will acquire Genzyme for around $20 billion.